Interact to see
Advertisement
Advertisement
BME vs XLV
BME vs XLV Comparison Chart in %
Loading...
Show more...
Show more...
View a ticker or compare two or three
VS
VS
BME vs. XLV commentary
Oct 18, 2025
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BME is a Hold and XLV is a Hold.
SUMMARIES
FUNDAMENTALS
Fundamentals
XLV has more net assets: 35.8B vs. BME (532M). BME has a higher annual dividend yield than XLV: BME (6.565) vs XLV (5.523). BME was incepted earlier than XLV: BME (21 years) vs XLV (27 years). XLV (0.08) has a lower expense ratio than BME (1.10). BME has a higher turnover XLV (2.00) vs XLV (2.00).
| BME | XLV | BME / XLV | |
| Gain YTD | 6.565 | 5.523 | 119% |
| Net Assets | 532M | 35.8B | 1% |
| Total Expense Ratio | 1.10 | 0.08 | 1,375% |
| Turnover | 29.00 | 2.00 | 1,450% |
| Yield | 0.35 | 1.75 | 20% |
| Fund Existence | 21 years | 27 years | - |
TECHNICAL ANALYSIS
Technical Analysis
| BME | XLV | |
|---|---|---|
| RSI ODDS (%) | 2 days ago 90% | 2 days ago 76% |
| Stochastic ODDS (%) | 2 days ago 82% | 2 days ago 71% |
| Momentum ODDS (%) | 2 days ago 82% | 2 days ago 87% |
| MACD ODDS (%) | 2 days ago 86% | 2 days ago 81% |
| TrendWeek ODDS (%) | 2 days ago 80% | 2 days ago 78% |
| TrendMonth ODDS (%) | 2 days ago 76% | 2 days ago 84% |
| Advances ODDS (%) | 3 days ago 77% | 3 days ago 82% |
| Declines ODDS (%) | 8 days ago 80% | 5 days ago 82% |
| BollingerBands ODDS (%) | 2 days ago 83% | 2 days ago 75% |
| Aroon ODDS (%) | 2 days ago 74% | 2 days ago 79% |
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement
Show more...
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| MSTSX | 12.24 | 0.08 | +0.66% |
| Morningstar Global Opportunistic Equity | |||
| NBHRX | 15.13 | 0.01 | +0.07% |
| Neuberger Berman Equity Income R3 | |||
| BIPIX | 56.46 | -0.10 | -0.18% |
| ProFunds Biotechnology UltraSector Inv | |||
| GEMIX | 29.85 | -0.06 | -0.20% |
| Goldman Sachs Emerging Markets Eq Instl | |||
| MINHX | 45.75 | -0.30 | -0.65% |
| MFS International Intrinsic Value R4 | |||
BME and
Correlation & Price change
A.I.dvisor tells us that BME and DHR have been poorly correlated (+16% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that BME and DHR's prices will move in lockstep.
1D
1W
1M
1Q
6M
1Y
5Y
| Ticker / NAME | Correlation To BME | 1D Price Change % | ||
|---|---|---|---|---|
| BME | 100% | +0.64% | ||
| DHR - BME | 16% Poorly correlated | -0.88% | ||
| UNH - BME | 12% Poorly correlated | -0.02% | ||
| ABBV - BME | 12% Poorly correlated | +1.19% | ||
| ABT - BME | 10% Poorly correlated | +0.71% | ||
| AMGN - BME | 9% Poorly correlated | +1.01% | ||
More | ||||
XLV and
Correlation & Price change
A.I.dvisor indicates that over the last year, XLV has been closely correlated with TMO. These tickers have moved in lockstep 72% of the time. This A.I.-generated data suggests there is a high statistical probability that if XLV jumps, then TMO could also see price increases.
1D
1W
1M
1Q
6M
1Y
5Y